EMA to review MAA for avalglucosidase alfa, enzyme replacement therapy to treat Pompe disease EP News Bureau Oct 2, 2020 The MHRA in the UK has granted Promising Innovative Medicine designation for avalglucosidase and US FDA has granted it…
